MDxHealth SA
CAP Business Center
Rue d’Abhooz 31 Zone Industrielle des Hauts-Sarts
Herstal 4040
Belgium
32 4 257 70 21
https://mdxhealth.com
版塊: Healthcare
行業: Diagnostics & Research
全職員工: 300
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Mr. Michael K. McGarrity | CEO & Executive Director | 759.49k | 無 | 1963 |
| Mr. Ron Kalfus CPA | Chief Financial Officer | 無 | 無 | 1974 |
| Mr. Joseph Sollee J.D., LLM | Executive VP of Corporate Development & General Counsel | 無 | 無 | 1965 |
| Mr. John A. Bellano | Chief Commercial Officer | 無 | 無 | 1969 |
| Ms. Miriam Reyes | Executive Vice President of Operations | 無 | 無 | 1973 |
| Dr. Jason Poole Ph.D. | Chief Scientific Officer | 無 | 無 | 無 |
描述
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. The company offers genomic prostate score which provides personalized genomic insights to both physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. It sells its products through urology sales force, consisting of direct sales representatives, strategic account managers, and regional sales managers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
公司管治
截至 2024年6月1日 止，MDxHealth SA 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中：7；董事會：5；股東權利：1；現金賠償：10。
